CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

ADARx prices $446.3M Nasdaq debut, continuing industry's IPO momentum

IPO/OfferingPositive
AI Analysis

Summary

ADARx Pharmaceuticals, an RNAi startup, completed an upsized Nasdaq IPO raising $446.3 million, contributing to strong biopharma industry IPO activity.

Importance:6/10
Sentiment:
0.60
IPORNAiNasdaqCapital Markets

Read the original article

Published by Endpoints News on September 25, 2026 7:46 AM

Read Original